Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Paroxetine hydrochloride
Cat. No.:
OB0225LY-0351
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Product Overview
Description:
Paroxetine hydrochloride is a selective 5-HT reuptake inhibitor (SSRI).
Synonym:
Paroxetine HCl; BRL29060 hydrochloride; FG-7051; BRL29060A; 78246-49-8; Paroxetine Hcl; (3S,4R)-3-[(2H-1,3-Benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine hydrochloride
CAS No.:
78246-49-8
Compound CID:
62878
Formula:
C19H21ClFNO3
Formula Weight:
365.826
Specification
Relative Density:
1.213 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Paroxetine hydrochloride can be used for research on mechanisms related to depression and anxiety disorders, etc.
Library Information
Targets:
5-HT receptor; GRK family; AChR; Serotonin transporter
Receptors:
GRK2
Pathways:
Autophagy; Neuronal signaling; GPCR/G protein
Plate Number:
AOCL-5
Plate Location:
e5
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
45 mg/mL; 123.01 mM
Water Max Solubility:
10 mg/mL; 27.33 mM
Ethanol Max Solubility:
35 mg/mL; 95.67 mM
